Uncategorized

Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs

Posted on

OTTAWA – Benzodiazepines and benzodiazepine-like prescription drugs (commonly referred to as “Z-drugs)—commonly used to treat sleep and anxiety disorders, certain seizure disorders, and to help relax muscles or relieve muscle pain—can lead to problematic use and substance use disorder. To help mitigate these risks, Health Canada is asking manufacturers to update their safety warnings to include more prominent and consistent messaging for patients and healthcare professionals.

Uncategorized

Non-prescription pain relief products containing codeine are not recommended for use in people under 18 years of age

Posted on

OTTAWA – The Government of Canada is committed to informing Canadians about the risks of health products that contain opioids. As a result, Health Canada is advising Canadians that people under 18 years of age should not use non-prescription pain relief products containing codeine. Non-prescription codeine-containing pain relief products were previously not recommended for children and youth under 12 years of age.

Uncategorized

The Hidden Deaths Of The COVID Pandemic

Posted on

Counting deaths caused by the coronavirus pandemic is easier said than done. Without widespread testing, officials must sort through presumed COVID deaths and those who died with infections rather than from them. Then there are the indirect deaths of people who died from circumstances created by the pandemic.